Soy Isoflavones

What is Soy Isoflavones?

The refined soybean isoflavone from non-transgenic soybean is a natural nutritional factor with many important physiological activities. It is a phytoestrogen that is easily absorbed by the human body.

Soybean isoflavones are phytoestrogens in the planned economy and a weak hormone. Soybean is the only effective source of isoflavones for human beings. Under the condition of strong physiological activity of estrogen, isoflavones can play an anti-estrogen role. Isoflavone has a very prominent anti-cancer property, which can hinder the growth and spread of cancer cells. Only cancer, isoflavone has no effect on normal cells. Isoflavones have antioxidant effects.

Uses, benefits, Side Effects

1. Alleviate female climacteric syndrome;

2. Prevent and fight cancer;

3. Treatment and prevention of prostate cancer;

4. Lower cholesterol and reduce the risk of heart disease;

5.Strengthen stomach and spleen, protect nervous system;

6.Reduce the cholesterol content of human body, prevent and treat cardiovascular diseases.

Currently, no side effects of this product have been documented in humans.

Application

1. In the field of food, soybean extracts are added to various drinks, Baijiu and food as functional food additives;

2. In the field of health care products, it is widely added to various health care products to prevent chronic diseases or alleviate symptoms of menopausal syndrome;

3. In the field of cosmetics, it is widely added to cosmetics, which has the function of delaying aging, tightening skin, and making skin more smooth and delicate.

Quality Control:

We controls product quality from the source, the establishment of a raw material base from seed, growth environment, field management, harvesting, packaging, warehousing, transportation and personal management.
1. The whole process of pesticide is using a monitoring system, more than 400 pesticide residues detected by European standards.
2. Comprehensive detection of lead, cadmium, mercury, cobalt, nickel, arsenic, vanadium and heavy metals in raw materials.
3. Determination of the content of the European Pharmacopoeia standard.